Evidence map›Paper›PMID 39994709›Full record

ArticleInternational journal for equity in health2025

Association of federal poverty level with healthcare expenditures among opioids users in the United States (2008-2019): a serial cross-sectional study.

Mark Bounthavong, Kangho Suh, Aryana Sepassi, Britney Stottlemyer, Patrick Spoutz, Laura Hart, Meng Li

Abstract read
In one paragraph

Article in International journal for equity in health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mark BounthavongSkaggs School of Pharmacy & Pharmaceutical Sciences, University of California San Diego, 9255 Pharmacy Lane, MC 0657, La Jolla, CA, 92093-0657, USA. mbounthavong@health.ucsd.edu.
Kangho SuhSchool of Pharmacy, University of Pittsburgh, 3501 Terrace St, Pittsburgh, PA, 15261, USA.
Aryana SepassiSchool of Pharmacy & Pharmaceutical Sciences, University of California Irvine, 856 Health Sciences Road, Irvine, CA, 92697, USA.
Britney StottlemyerSchool of Pharmacy, University of Pittsburgh, 3501 Terrace St, Pittsburgh, PA, 15261, USA.
Patrick SpoutzUS Department of Veterans Affairs, Pharmacy Benefits Management, 500 West Fort Street, Boise, ID, 83702-4501, USA.
Laura HartPlein Center for Aging, University of Washington, 1959 NE Pacific Street, Box 357630, Seattle, WA, 98195-7630, USA.
Meng LiCenter for the Evaluation of Value and Risk in Health, Tufts Medical Center, 800 Washington St, Boston, MA, 02111, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOpioid users across federal poverty levels have varying healthcare consumption, which could influence public health policies to address the opioid crisis. To better understand this relationship, we evaluated the associations between federal poverty level (FPL) with healthcare costs and utilizations among adult opioid users in the United States (US).

methodsA serial cross-sectional study using pooled data (2008-2019) from the Medical Expenditure Panel Survey (MEPS) was used to evaluate the association between FPL with healthcare expenditures among a representative sample of the US adult population with > = 1 opioid prescription. FPL was defined as Poor/Near Poor-Income, Low-Income, Middle-Income, and High-Income. Healthcare expenditures included costs and resource utilization. Survey weights were applied to generate standard errors for the representative sample of the US population. Generalized linear models were constructed to evaluate the association between FPL and healthcare expenditures adjusting for confounders. FPL groups were stratified by insurance coverage, frequency of opioid prescriptions filled, and pain level to evaluate their impact on healthcare expenditures.

resultsTotal weighted sample was 27,289,263 respondents; 21.6% in Poor/Near Poor-Income, 14.9% in Low-Income, 28.6% in Middle-Income, and 34.9% in High-Income groups. The average annual increase in total healthcare costs for the Poor/Near Poor-Income group was $451 (95% CI: $142-$761), $275 (95% CI: $48-$502) for the Low-Income group, $640 (95% CI: $447-$834) for the Middle-Income group, and $618 (95% CI: $360-$877) for the High-Income group. Between-group comparisons yielded significant increases in average annual total healthcare costs for Middle- and High-Income groups versus Low-Income group; significant increases in average annual emergency room costs between Middle- versus Low-Income groups, and significant increases in average annual inpatient costs between Middle-Income versus Poor/Near Poor- and Low-Income groups. Stratified analyses yielded several significant increases in average annual costs and expenditures. However, no differences were reported for respondents who were uninsured across FPL groups.

conclusionsRespondents across FPL groups consumed healthcare at various rates, particularly when stratified by insurance coverage, frequency of opioid prescriptions filled, and pain level. FPL plays an important role in healthcare consumption, but further research is needed to understand these mechanisms and their impact on the opioid crisis.

Indexed as

Analgesics, OpioidHealth ExpendituresPovertyAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedOpioid-Related DisordersUnited StatesAnalgesics, OpioidCostsFederal poverty levelHealthcare consumptionHealthcare expendituresMedical Expenditure Panel SurveyOpioidsUnited StatesUtilization

Identifiers

PMID39994709
PMCPMC11849152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.